TransDigm said net sales for the 13 weeks ended June 28, 2025 were $2,237 million, up 9.3% from $2,046 million in the prior year's period, and net income was $493 million, up 6.9%.

1. 01

   TransDigm said net sales for the 13 weeks ended June 28, 2025 were $2,237 million, up 9.3% from $2,046 million in the prior year's period, and net income was $493 million, up 6.9%.

2. 02

   The company said EBITDA As Defined for Q3 was $1,217 million, up 11.5%, and EBITDA As Defined as a percentage of net sales was 54.4% compared with 53.3% in the prior year's quarter. Adjusted earnings per share were $9.60 compared with $9.00 in the prior year's quarter.

3. 03

   TransDigm provided fiscal 2025 net sales guidance of $8,760 million to $8,820 million and EBITDA As Defined guidance of $4,695 million to $4,755 million. At the midpoint, the company decreased net sales guidance by $60 million and increased EBITDA As Defined guidance by $40 million.

4. 04

   The company said it completed a private offering of $2,650 million of 6.375% Senior Subordinated Notes due May 31, 2033 on Q3 and used the net proceeds plus cash on hand to redeem all $2,650 million of 5.50% Senior Subordinated Notes due 2027. Subsequent to the quarter, it said it entered into a definitive agreement to acquire Simmonds for approximately $765 million in cash.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.